MedPath

Additional injection to prevent infection after cesearean delivery

Phase 3
Completed
Conditions
Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperiumHealth Condition 2: null- Pregnant women completed 37 weeks undergoing cesarean section
Registration Number
CTRI/2015/10/006329
Lead Sponsor
internal fluid research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
2000
Inclusion Criteria

pregnant women with completed 37 weeks undergoing cesarean section

Exclusion Criteria

Patients with known allergy to Cephalosporin and Azithromycin

Patient who have received antibiotics within a week prior to the delivery or intrapartum propylaxis for chorioamnionitis.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath